Call us on 0345 60 00 550 Email us info@zod.uk.com

Developing and Supporting Online Business for Over 17 Years
London
Dubai
Singapore
Caribbean

Via Recruit - Pharmaceutical Recruitment04/2011

Via Recruit are a pharmaceutical recruitment specialist dealing with positions in the ICT, Pharmaceutical, Biotechnology, Healthcare and Life Science sectors and they have recently launched their new website with our Recruitment Agency website system.

This is their launch press release:

Via Recruit is the leading recruitment specialist for the ICT, Pharmaceutical, Biotechnology, Healthcare and Life Science sectors. They have a comprehensive range of services including:

A Global coverage and reach spanning tens of thousands of specialist job roles.
Unique fully qualified contact base of more than 250,000 potential applicants.

Highly experienced domain specialists, who have worked in the sector and many of their consultants have worked in the sectors that they specialise in recruiting for.

They are actively involved in the industry, sponsoring events and advising multinational corporations on industry best practice.

They offer Permanent, Contract and Interim Pharmaceutical roles. The sectors they cover include Information Technology & Telecommunications, Sales, Marketing & Commercial, Drug Safety & Pharmacovigilance, Human Resources, Medical Communications, Health Economics & Outcomes Research, Quality Assurance & Quality Control, Regulatory Affairs, Research & Development, Supply Chain, Packaging & Distribution, Statistics & SAS and Clinical Research.

Their new uses the core functionality of Zero-One Design's powerful recruitment agency website system, is fully updateable and includes new job search functionality, jobs by email systems, social media marketing tools and third party job posting to a number of third party jobs boards. The website was created by Zero-One Design, recruitment website design specialists, based in Tamworth, Staffs.

Visit www.viarecruit.com and see for yourself.

 

© SaaS Holdings Limited 2026.